Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching (Q36557966)

14 August 2017

Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching (English)

1 reference

14 August 2017

1 reference

Hilde-Kari Guttormsen

1 reference

14 August 2017

Lawrence C Paoletti

1 reference

14 August 2017

Keith G Mansfield

1 reference

14 August 2017

Wojcieck Jachymek

1 reference

14 August 2017

Harold J Jennings

1 reference

14 August 2017

Dennis L Kasper

1 reference

14 August 2017

language of work or name

English

0 references

publication date

31 March 2008

1 reference

Proceedings of the National Academy of Sciences of the United States of America

14 August 2017

1 reference

14 August 2017

105

1 reference

14 August 2017

1 reference

14 August 2017

5903-5908

1 reference

Serotype IX, a Proposed New Streptococcus agalactiae Serotype

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Global epidemiology of meningococcal disease and vaccine efficacy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Polysialic acid and mucin type o-glycans on the neural cell adhesion molecule differentially regulate myoblast fusion.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Glycoconjugate vaccines to prevent group B streptococcal infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Potency of clinical group B streptococcal conjugate vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Conformational epitope of the type III group B Streptococcus capsular polysaccharide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

30 September 2017

https://api.crossref.org/works/10.1073%2FPNAS.0710799105

Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immunodeterminant specificity of human immunity to type III group B streptococcus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Group B streptococcal disease in nonpregnant adults

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2311338

Invasive group B streptococcal disease: the emergence of serotype V

21 September 2018

1 reference

12 December 2020

Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus

1 reference

12 December 2020

Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide

1 reference

12 December 2020

Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci

1 reference

12 December 2020

Complete amino acid sequence of protein B

1 reference

12 December 2020

Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide

1 reference

12 December 2020

Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide

1 reference

12 December 2020

Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines

1 reference

12 December 2020

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

1 reference

12 December 2020

Neonatal mouse model of group B streptococcal infection

1 reference

12 December 2020

Type V group B streptococcal septicaemia with bilateral endophthalmitis and septic arthritis

1 reference

12 December 2020

Neonatal sepsis caused by a new group B streptococcal serotype

1 reference

12 December 2020

Group B streptococcus serotype V

1 reference

12 December 2020

Emergence of serotype V group B streptococcal infection among infants and adults

1 reference

12 December 2020

Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy

1 reference

12 December 2020

Quantitative determination of antibodies to type III group B streptococcal polysaccharide

1 reference

12 December 2020

Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0710799105

1 reference

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

18378894

1 reference